Most Popular
-
1
Dongduk Women’s University halts coeducation talks
-
2
Defense ministry denies special treatment for BTS’ V amid phone use allegations
-
3
Russia sent 'anti-air' missiles to Pyongyang, Yoon's aide says
-
4
OpenAI in talks with Samsung to power AI features, report says
-
5
Two jailed for forcing disabled teens into prostitution
-
6
Trump picks ex-N. Korea policy official as his principal deputy national security adviser
-
7
South Korean military plans to launch new division for future warfare
-
8
Gold bars and cash bundles; authorities confiscate millions from tax dodgers
-
9
Kia EV9 GT marks world debut at LA Motor Show
-
10
Teen smoking, drinking decline, while mental health, dietary habits worsen
[THE INVESTOR] LG Life Science announced on Sept. 1 that it is releasing two kinds of fillers containing lidocaine, a local anesthesia, in China.
The biopharmaceutical arm of LG is launching Yvoire Classic Plus and Yvoire Volume Plus, dermal wrinkle fillers equipped with the solution to relieve pain upon administration.
LG has won approval for sales from China Food and Drug Administration in April, the first for an imported filler containing lidocaine.
The South Korean company’s dermal filler range has posted 18.5 billion won (US$16.51 million) in sales in the second quarter of this year, doubling from the same period last year. About 75 percent of the sales came from exports, with China being its main market.
By Hwang You-mee (glamazon@heraldcorp.com)
The biopharmaceutical arm of LG is launching Yvoire Classic Plus and Yvoire Volume Plus, dermal wrinkle fillers equipped with the solution to relieve pain upon administration.
LG has won approval for sales from China Food and Drug Administration in April, the first for an imported filler containing lidocaine.
The South Korean company’s dermal filler range has posted 18.5 billion won (US$16.51 million) in sales in the second quarter of this year, doubling from the same period last year. About 75 percent of the sales came from exports, with China being its main market.
By Hwang You-mee (glamazon@heraldcorp.com)
